Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients.
暂无分享,去创建一个
J. McKiernan | C. Olsson | A. De la taille | M. Burchardt | R. Buttyan | A. Katz | I. Sawczuk | Y. Cao | T. Burchardt | D. Chopin | O. Hayek
[1] Katz,et al. Biomarkers of renal cell carcinoma. Past and future considerations. , 2000, Urologic oncology.
[2] M. Rubin,et al. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9 , 1999, Cancer.
[3] D. Bostwick,et al. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma , 1998, Cancer.
[4] E. Stanbridge,et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. , 1997, Cancer research.
[5] M. Stifelman,et al. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. , 1997, Cancer research.
[6] C. Cordon-Cardo,et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] J. Schalken,et al. Molecular prognostic factor in renal cell carcinoma. , 1996, Seminars in urologic oncology.
[8] G. Snow,et al. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. , 1996, Anticancer research.
[9] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[10] E. Levine,et al. Detection of tyrosinase mRNA from the blood of melanoma patients. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] B. Lacour,et al. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. , 1995, Clinical chemistry.
[12] J. Isaacs,et al. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. , 1995, Genomics.
[13] K. Pittman,et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.
[14] P. Schellhammer,et al. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. , 1995, Urologic oncology.
[15] R. Kettmann,et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.
[16] P. Disaia,et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. , 1994, The American journal of pathology.
[17] M. Benson,et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. , 1994, Urology.
[18] W. Fair,et al. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. , 1993, Cancer research.
[19] W. L. Davis,et al. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. , 1990, Cancer research.
[20] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.